Sacroiliac Joint Fusion Market Report 2026

The sacroiliac joint fusion market size has grown rapidly in recent years. It will grow from $0.8 billion in 2025 to $0.94 billion in 2026 at a compound annual growth rate (CAGR) of 18%. The growth in the historic period can be attributed to growing prevalence of lower back pain disorders, increased diagnosis of sacroiliac joint dysfunction, availability of fusion implant systems, expansion of spine surgery expertise, adoption of minimally invasive surgical approaches.

The sacroiliac joint fusion market size is expected to see rapid growth in the next few years. It will grow to $1.7 billion in 2030 at a compound annual growth rate (CAGR) of 16%. The growth in the forecast period can be attributed to increasing demand for outpatient orthopedic procedures, rising adoption of advanced spinal implants, growing focus on faster patient recovery, expansion of image-guided surgical systems, increasing investments in orthopedic innovation. Major trends in the forecast period include increasing adoption of minimally invasive fusion procedures, rising use of advanced implant technologies, growing demand for image-guided surgical techniques, expansion of outpatient spine surgery settings, enhanced focus on long-term pain management.

The rising prevalence of lower back pain is expected to drive the growth of the sacroiliac joint fusion market in the coming years. Lower back pain refers to discomfort or pain in the lumbar region of the spine, which spans the area between the bottom of the rib cage and the top of the legs. It is a common condition that can range from a dull, constant ache to sudden, sharp pain. Factors contributing to the prevalence of lower back pain include work-related stress, sedentary lifestyles, obesity, and dietary habits. Sacroiliac joint fusion helps alleviate lower back pain and enhances overall function and quality of life by stabilizing the joint and reducing abnormal movement. For example, in May 2023, an article published by the National Center for Biotechnology Information, a US-based government agency, reported that low back pain affected 619 million people worldwide in 2020, with projections reaching 843 million by 2050. Therefore, the increasing prevalence of lower back pain is driving growth in the sacroiliac joint fusion market.

Leading companies in the sacroiliac joint fusion market are focusing on innovative implants, such as granite implant systems, to improve patient outcomes, reduce surgical time, and enhance procedural effectiveness. The granite implant system for SI joint fusion is designed to treat conditions affecting the sacroiliac joint, such as sacroiliac joint dysfunction or sacroiliitis, providing effective joint stabilization and fusion to improve quality of life. For instance, in May 2024, SI-BONE Inc., a UK-based healthcare company specializing in surgical treatment of musculoskeletal disorders, launched the iFuse Bedrock Granite Implant System. This advanced implant features a smaller diameter designed for sacroiliac fusion and spinopelvic fixation, which is crucial for multi-segment spinal fusion procedures. The implant received Breakthrough Device Designation from the FDA and a new technology add-on payment from CMS. The iFuse Bedrock Granite Implant System represents a major advancement in treating SI joint dysfunction, offering a reliable and effective option for patients with chronic lower back pain related to SI joint issues.

In November 2023, Nevro Corp, a US-based medical device company, acquired Vyrsa Technologies for $75 million. This acquisition was a strategic move by Nevro to expand its portfolio by incorporating Vyrsa’s expertise in minimally invasive treatments for patients suffering from chronic sacroiliac (SI) joint pain. Vyrsa Technologies, based in the US, specializes in minimally invasive solutions for patients with chronic SI joint pain.

Major companies operating in the sacroiliac joint fusion market are Medtronic Plc, Zimmer Biomet Holdings Inc., Integra LifeSciences, NuVasive Inc., Globus Medical, Orthofix Inc., Medacta International SA, Alphatec Holdings Inc., RTI Surgical Holdings Inc., SeaSpine, SI-BONE Inc., Surgalign Holdings Inc., Xtant Medical, CoreLink, Life Spine Inc., Genesys Spine, Camber Spine Technologies LLC, Captiva Spine Inc., VGI Medical LLC, PainTEQ, CornerLoc, SIGNUS Medizintechnik GmbH, Tenon Medical Inc.

North America was the largest region in the sacroiliac joint fusion market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sacroiliac joint fusion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sacroiliac joint fusion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the sacroiliac joint fusion market by increasing costs of imported surgical implants, titanium alloys, imaging equipment, and specialized instrumentation kits. Hospitals and surgical centers in North America and Europe are most affected due to reliance on imported orthopedic devices, while Asia-Pacific faces pricing pressure on implant exports. These tariffs are increasing procedural costs and impacting capital equipment purchasing. However, they are also encouraging domestic implant manufacturing, localized device assembly, and greater investment in regional orthopedic production capabilities.

The sacroiliac joint fusion market research report is one of a series of new reports that provides sacroiliac joint fusion market statistics, including sacroiliac joint fusion industry global market size, regional shares, competitors with a sacroiliac joint fusion market share, detailed sacroiliac joint fusion market segments, market trends and opportunities, and any further data you may need to thrive in the sacroiliac joint fusion industry. This sacroiliac joint fusion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Sacroiliac joint fusion is a surgical procedure designed to relieve pain originating from the sacroiliac joint by permanently joining the sacrum (the triangular bone at the base of the spine) to the ilium (part of the pelvis) using surgical implants or bone grafts. This fusion restricts motion in the joint, reducing or eliminating pain caused by joint instability, inflammation, or degenerative conditions.

The main product types for sacroiliac joint fusion include implants, accessories, injections, diagnostics, treatments, and RF ablation. Implants used in SI joint fusion are medical devices intended to stabilize and promote fusion of the SI joint. The procedure addresses indications such as degenerative sacroiliitis, sacral disruption, and trauma, using various approaches including dorsal and anterior. These procedures are carried out by a range of end users, including hospitals, ambulatory surgical centers, and others.

The sacroiliac joint fusion market consists of revenues earned by entities through surgical procedures, diagnostic services, rehabilitation and post-operative care, consultation services, and hospital and surgical center services. The market value includes the value of related goods sold by the service provider or included within the service offering. The sacroiliac joint fusion market also includes sales of SI joint fusion implants, surgical instruments, bone grafts and substitutes, navigation and imaging systems, fixation devices, and minimally invasive surgical kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.